The EGFR status did not correlate with disease-specific survival (DSS, p = 0.551), tumor localization (p = 0.369), tumor size (p = 0.690), lymph-node metastasis (p = 0.525), distant metastasis (p = 0.522), stage (p = 0.182), smoking (p = 0.866) or alcohol consumption (p = 0.707). Here, EGFR is linked to metastatic malignant neoplasm in the lymph nodes.